title: Astellas' lawsuit against Prescrire: French court rules that prescrire did not "denigrate" protopic (tacrolimus).
abstract: A Paris court handed down its ruling on 2 March, rejecting a suit brought by pharmaceutical company Astellas against the French journal Prescrire. At a time when French society is reeling in the wake of the scandal caused by weight-loss drug Mediator (benfluorex), the 2 March ruling comes as very good news for healthcare professionals and for patients.
mesh_terms: D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004345:Drug Industry; D005602:France; D006801:Humans; D007603:Jurisprudence; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D016559:Tacrolimus